<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          Global EditionASIA 中文雙語Fran?ais
          Business
          Home / Business / Latest

          Eli Lilly promotes new drug at CIIE

          By SHI JING in Shanghai | chinadaily.com.cn | Updated: 2019-11-09 09:43
          Share
          Share - WeChat

          Indianapolis-headquartered pharmaceutical company Eli Lilly and Company attended the second China International Import Expo with its latest medicine Taltz to moderate severe plaque psoriasis.

          During the news conference on Thursday, a total of 17 Chinese domestic pharmaceutical companies signed intention agreements with Eli Lilly for the purchase of Taltz. The medicine has been approved by China's National Products Administration in September.

          Eli Lilly and Company was not present at last year's CIIE. Julio Gay-Ger, president and general manager of Lilly China, said that they "were positively surprised by the huge success that CIIE had last year".

          "So we really want to be part of the CIIE in the second year. We have had in the last 12 months five new molecular entities launched in China. This is very close to our record. More importantly, we have up to 40 new launches in the next seven to 10 years. We are bringing innovations to Chinese patients which will make a huge difference to them," he said.

          Gay-Ger said the company has had expectations for Lilly China's sales and business growth.

          "China is the second-largest pharmaceutical market in the world today. It is supposed to be the No 1 pharmaceutical market in the future. It is our top priority market and that is why we are investing so heavily and bringing so much innovation here," he said.

          Lilly set up its Shanghai office in 1918, which was the first overseas office for the US pharmaceutical company. Lilly China's overall growth rate for the first half of 2019 exceeded 30 percent, reaching a record high throughout the company's 101-year history in China.

          Ever since 2013, Lilly has invested about $320 million to build an insulin production facility in Suzhou. The site is set to be an integral part of Lilly's global supply chain, providing insulin products for China, Europe and other markets across the world in 2019.

          "In the future, we can have new launches in China simultaneously or almost simultaneously with other markets in the world. That progress is in part because of the great reform that government is taking, which offers great opportunity to have all that happen," he said.

          Top
          BACK TO THE TOP
          English
          Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          CLOSE
           
          主站蜘蛛池模板: 办公室强奷漂亮少妇视频| 国产黄色一区二区三区四区| 亚洲精品天堂一区二区| 亚洲av天码一区二区| 92国产精品午夜福利免费| 99在线国内在线视频22| 永久免费av无码网站直播| 免费VA国产高清大片在线| 国产激情艳情在线看视频| 国产亚洲精品第一综合另类| 国产成人无码A区在线观看视频| 精品人妻免费看一区二区三区| 国产午夜亚洲精品不卡网站| 亚洲综合黄色的在线观看| 国产亚洲国产精品二区| 久久99精品久久水蜜桃| 日韩精品亚洲专区在线观看| 亚洲色一区二区三区四区| 久久香蕉欧美精品| 无码人妻h动漫| 欧美日韩视频综合一区无弹窗| 久久精品国产福利一区二区| 亚洲天堂亚洲天堂亚洲色图 | 国产亚洲欧洲av综合一区二区三区| 久久精品国产亚洲av天海翼| 亚洲尤码不卡av麻豆| 无码天堂亚洲国产AV| 中文字幕亚洲人妻一区| 精品欧美小视频在线观看| 国产偷自一区二区三区在线| 国产在线观看免费观看| 成人国产亚洲精品天堂av| 久久久久无码中| 国产精品老熟女一区二区| 国产精品国产三级国产a| 国产av剧情无码精品色午夜| 久久99精品久久久久久齐齐| 奇米影视7777久久精品| 人妻精品动漫H无码中字| 日本高清视频网站www| 奇米四色7777中文字幕|